<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-34">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <collab>VISR Working Group of Global HIV Vaccine Enterprise</collab>, 
  <person-group person-group-type="author">
   <name>
    <surname>Voronin</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zinszner</surname>
    <given-names>H</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians.</article-title>
  <source>
   <italic toggle="yes">Vaccine.</italic>
  </source>
  <year>2015</year>;
  <volume>33</volume>(
  <issue>10</issue>):
  <fpage>1243</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.10.040</pub-id>
  <!--<pub-id pub-id-type="pmcid">4331207</pub-id>-->
  <?supplied-pmid 25649349?>
  <pub-id pub-id-type="pmid">25649349</pub-id>
 </mixed-citation>
</ref>
